eysuvis
(loteprednol etabonate)ALCON LABORATORIES, INC.
Usage: EYSUVIS is a corticosteroid indicated for the short-term treatment (up to two weeks) of signs and symptoms associated with dry eye disease.
5 results
lacrisert
(hydroxypropyl cellulose)Bausch & Lomb IncorporatedUsage: LACRISERT is indicated for treating moderate to severe dry eye syndromes, including keratoconjunctivitis sicca, particularly in patients who do not respond adequately to artificial tears. It is also used for exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.miebo
(Perfluorohexyloctane)Bausch & Lomb IncorporatedUsage: MIEBO® (perfluorohexyloctane ophthalmic solution) is indicated for treating the signs and symptoms of dry eye disease (DED).tyrvaya
(varenicline)Oyster Point PharmaUsage: TYRVAYA (varenicline solution) nasal spray is indicated for treating the signs and symptoms associated with dry eye disease.xiidra
(Lifitegrast)Novartis Pharmaceuticals CorporationUsage: Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for treating the signs and symptoms of dry eye disease (DED).